EU orders 30,000 remdesivir coronavirus treatments
This transmission electron microscope image shows SARS-CoV-2 -- also known as 2019-nCoV, the virus that causes COVID-19 -- isolated from a patient in the US. Virus particles are shown emerging from the surface of cells cultured in the lab. The spikes on the outer edge of the virus particles give coronaviruses their name, crown-like. Credit: NIAID-RML
The European Commission has ordered 30,000 treatment doses of the antiviral medication remdesivir from US drugs giant Gilead, it announced Wednesday.
Sold under the brand name Veklury, remdesivir is the first medicine to be approved by the EU to treat victims of the COVID-19 pandemic in EU member states and Britain.
It is hoped the drug will shorten recovery times for patients with severe infections and it will be made available early next month.
The first batch of doses will cost 63 million euros ($73 million) and ought to cover needs for the next few months before a second procurement contract in October.
Citation:
EU orders 30,000 remdesivir coronavirus treatments (2020, July 29)
retrieved 8 June 2023
from https://medicalxpress.com/news/2020-07-eu-remdesivir-coronavirus-treatments.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
Let us know if there is a problem with our content
E-mail the story
EU orders 30,000 remdesivir coronavirus treatments
Your Privacy
This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties.
By using our site, you acknowledge that you have read and understand our Privacy Policy
and Terms of Use.
